Evaxion A (EVAX) Other Accumulated Expenses (2020 - 2025)
Evaxion A (EVAX) posted Other Accumulated Expenses of $1.2 million for Q2 2025, up 24.6% on a QoQ basis from $927000.0 in Q4 2024, and up 56.5% year-over-year from $738000.0 in Q2 2024.
Evaxion A (EVAX) Other Accumulated Expenses (2020 - 2025) Analysis & Trends
Evaxion A's Other Accumulated Expenses history runs 6 years deep, the most recent figure standing at $1.2 million for Q2 2025.
- Quarterly Other Accumulated Expenses rose 56.5% year-over-year to $1.2 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $1.2 million (up 56.5% YoY) and the FY2024 annual result came in at $927000.0, down 7.85% from the prior year.
- Other Accumulated Expenses was $1.2 million for Q2 2025 at Evaxion A, up from $927000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $3.1 million in Q2 2021 and bottomed at $665000.0 in Q4 2022.
- A 5-year average of $1.4 million and a median of $1.0 million in 2021 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2022 — Other Accumulated Expenses sank 70.86% — and 2023, when it surged 60.02%.
- Evaxion A's Other Accumulated Expenses stood at $1.0 million in 2021, then tumbled by 35.75% to $665000.0 in 2022, then surged by 51.28% to $1.0 million in 2023, then retreated by 7.85% to $927000.0 in 2024, then rose by 24.6% to $1.2 million in 2025.
- Business Quant data shows EVAX's Other Accumulated Expenses at $1.2 million in Q2 2025, $927000.0 in Q4 2024, and $738000.0 in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - |
| 2 | Nanobiotix | 1,911.11 Bn | 1,911.05 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 467.81 Bn | 463.02 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.92 Bn | 115.68 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.28 Bn | 61.53 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.88 Bn | 62.88 Bn | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Evaxion A | 1.24 Bn | 1.24 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1.16 Mn |
| Dec 31, 2024 | 927,000.00 |
| Jun 30, 2024 | 738,000.00 |
| Dec 31, 2023 | 1.01 Mn |
| Jun 30, 2023 | 1.49 Mn |
| Dec 31, 2022 | 665,000.00 |
| Jun 30, 2022 | 933,000.00 |
| Mar 31, 2022 | 744,000.00 |
| Dec 31, 2021 | 1.04 Mn |
| Sep 30, 2021 | 2.91 Mn |
| Jun 30, 2021 | 3.11 Mn |
| Mar 31, 2021 | 2.55 Mn |
| Dec 31, 2020 | 2.26 Mn |